Nestlé injects cash into Enterome in food allergy, IBD collaboration
Nestlé is providing EUR40m (US$40.7m) to Paris-based Enterome in a project targeting food allergies and inflammatory bowel disease (IBD).
Source: just-food.com
Stay updated with breaking news from Paris Based Enterome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nestlé is providing EUR40m (US$40.7m) to Paris-based Enterome in a project targeting food allergies and inflammatory bowel disease (IBD).
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the goal of priming the translational pump in hot areas where European academics have already made a mark, particularly the microbiome.